Reversible renal impairment induced by treatment with the angiotensin II receptor antagonist candesartan in a patient with bilateral renal artery stenosis
<p>Abstract</p> <p>Background</p> <p>It is well established that ACE-inhibitors should be avoided in patients with renal artery stenosis. In recent years it has also been recommended that caution should be demonstrated when angiotensin II blockers are used in the same t...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2001-05-01
|
Series: | BMC Nephrology |
Online Access: | http://www.biomedcentral.com/1471-2369/2/1 |